{"product_id":"mots-c-pen","title":"MOTS-c | Pen","description":"\u003cp\u003eMOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino-acid, mitochondrial-encoded peptide studied as a regulator of metabolic signaling and cellular stress adaptation. In research models, MOTS-c is explored for its association with energy sensing pathways (notably AMPK-linked signaling), substrate utilization, and insulin-sensitivity readouts across diet, aging, and exercise-stress paradigms. Information on this page is provided for scientific and educational context only and does not represent medical guidance or therapeutic claims.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSupports\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eMetabolic signaling endpoints associated with cellular energy sensing and AMPK-linked pathways.\u003c\/li\u003e\n\u003cli\u003eGlucose utilization and insulin-sensitivity readouts tracked in metabolic stress and diet models.\u003c\/li\u003e\n\u003cli\u003eFat-oxidation and substrate-flexibility frameworks assessed in endurance and body-composition studies.\u003c\/li\u003e\n\u003cli\u003eCellular stress-response markers evaluated in oxidative and inflammatory challenge paradigms.\u003c\/li\u003e\n\u003cli\u003eHealthy-aging research endpoints linking mitochondrial signaling to resilience and performance markers.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is part of a broader class of “mitochondrial-derived peptides” (MDPs) investigated for their role in mitochondria-to-nucleus communication and whole-body metabolic regulation. Unlike most peptides used in research, MOTS-c is encoded by mitochondrial DNA and is studied in contexts where energy availability and cellular stress alter metabolic decisions at the tissue level.\u003c\/p\u003e\n\u003cp\u003eIn experimental systems, MOTS-c is commonly positioned in metabolic homeostasis research—particularly designs that measure glucose tolerance, insulin signaling efficiency, lipid utilization, and mitochondrial adaptation under caloric excess, aging, or exercise-like stress. Mechanistic discussions frequently highlight AMPK-linked signaling and downstream transcriptional programs involved in metabolic flexibility and stress resilience.\u003c\/p\u003e\n\u003cp\u003eMOTS-c is presented here for controlled research and educational context only. It is not marketed on this page as an approved therapeutic product, and reported observations can vary substantially by model, endpoints, and study design.\u003c\/p\u003e\n\u003ch2\u003eClinical Status\u003c\/h2\u003e\n\u003cp\u003eMOTS-c has extensive preclinical and mechanistic literature, plus human observational work examining endogenous MOTS-c levels and associations with metabolic markers. Interventional human evidence is still limited and remains study-specific.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEvidence type:\u003c\/strong\u003e\u003cbr\u003eHuman RCT ✔ | Observational ✔ | Animal ✔ | In vitro ✔ | Regulatory approval ☐\u003c\/p\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eMechanistic models of MOTS-c describe it as an energy-stress responsive signal that can influence metabolic programs and cellular adaptation. In multiple research contexts, MOTS-c is associated with \u003cstrong\u003eAMPK-linked signaling\u003c\/strong\u003e and shifts in substrate handling (glucose utilization and fatty-acid oxidation), alongside broader transcriptional changes relevant to mitochondrial adaptation and stress resistance.\u003c\/p\u003e\n\u003cp\u003eDepending on model design, reported downstream readouts include changes in insulin-signaling markers, oxidative stress indicators, and gene expression patterns tied to metabolic flexibility. Outcomes remain endpoint-dependent and can differ by tissue, dosing paradigm, and challenge condition.\u003c\/p\u003e\n\u003ch2\u003eBenefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eActivation of AMPK and Metabolic Regulation\u003c\/b\u003e:\u003cbr\u003eMOTS-c is a mitochondria-derived peptide studied for its role in activating the\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eAMPK signaling pathway\u003c\/b\u003e, which enhances glucose uptake, fatty acid oxidation, and cellular energy balance. Through this mechanism, it improves metabolic flexibility and overall energy efficiency, positioning it as a core peptide in research on metabolic optimization and cellular homeostasis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eImproved Insulin Sensitivity and Glucose Utilization\u003c\/b\u003e:\u003cbr\u003ePreclinical and human studies demonstrate that MOTS-c enhances\u003cspan\u003e \u003c\/span\u003e\u003cb\u003einsulin sensitivity and glucose tolerance\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eby promoting GLUT4 translocation and regulating key enzymes in glucose metabolism. These effects make it a central compound in experimental models addressing insulin resistance, metabolic syndrome, and energy regulation disorders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePromotion of Fat Oxidation and Weight Management\u003c\/b\u003e:\u003cbr\u003eThrough its influence on AMPK and mitochondrial metabolism, MOTS-c increases\u003cspan\u003e \u003c\/span\u003e\u003cb\u003elipid utilization and fat oxidation\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ein skeletal muscle and adipose tissue. This shift toward efficient fat burning has been associated with reduced weight gain and improved body composition in animal models subjected to high-fat diets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eEnhanced Mitochondrial Function and Energy Production\u003c\/b\u003e:\u003cbr\u003eResearch shows that MOTS-c enhances\u003cspan\u003e \u003c\/span\u003e\u003cb\u003emitochondrial respiration and biogenesis\u003c\/b\u003e, resulting in improved ATP synthesis and reduced oxidative stress. These effects contribute to greater cellular resilience, especially under metabolic or physical stress, making it a promising agent in studies of mitochondrial health and longevity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eResistance to Metabolic Stress and Aging\u003c\/b\u003e:\u003cbr\u003eIn aging models, MOTS-c has been observed to\u003cspan\u003e \u003c\/span\u003e\u003cb\u003epreserve metabolic balance and physical performance\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eunder stress conditions such as high-fat feeding or fasting. It supports homeostasis by maintaining mitochondrial function and reducing age-associated metabolic decline, highlighting its potential relevance in anti-aging and gerontology research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eEnhancement of Exercise Endurance and Muscle Function\u003c\/b\u003e:\u003cbr\u003eMOTS-c has been shown to\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eincrease exercise capacity and endurance\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ethrough improved muscle energy metabolism and reduced lactate accumulation. These findings indicate that it may optimize substrate utilization during prolonged activity, making it a leading candidate for research into athletic performance and energy efficiency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eProtection Against Oxidative and Cellular Stress\u003c\/b\u003e:\u003cbr\u003eStudies reveal that MOTS-c enhances\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eantioxidant defenses\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eby regulating stress-response genes such as NRF2 and FOXO3a. This activity helps protect mitochondria and DNA from oxidative damage, supporting cellular integrity and long-term health in research on aging and stress resistance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eModulation of Inflammatory Pathways\u003c\/b\u003e:\u003cbr\u003eMOTS-c demonstrates\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eanti-inflammatory properties\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eby reducing the production of cytokines including IL-6, TNF-α, and CRP in experimental models. This contributes to systemic balance and supports ongoing research into chronic inflammation, metabolic disorders, and longevity-linked pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNeuroprotective and Cognitive Supportive Effects\u003c\/b\u003e:\u003cbr\u003eEmerging data suggest that MOTS-c can\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eprotect neurons from oxidative damage\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eand improve cognitive resilience under metabolic stress. Its regulation of mitochondrial activity in neural tissues supports research exploring its role in brain energy metabolism and neurodegenerative disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSupport for Longevity and Healthy Aging\u003c\/b\u003e:\u003cbr\u003eLong-term studies indicate that MOTS-c expression declines with age, and supplementation restores youthful\u003cspan\u003e \u003c\/span\u003e\u003cb\u003emetabolic and mitochondrial profiles\u003c\/b\u003e. Its capacity to sustain energy homeostasis, reduce inflammation, and prevent insulin resistance positions it as a key peptide in aging and lifespan extension research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSynergistic Potential with NAD+ and SS-31\u003c\/b\u003e:\u003cbr\u003eWhen combined with mitochondrial-targeted compounds such as\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eNAD+ or SS-31\u003c\/b\u003e, MOTS-c shows synergistic effects on oxidative phosphorylation, energy output, and protection against cellular aging. These combinations are under study for enhancing mitochondrial resilience and overall vitality in long-term metabolic health models.\u003c\/li\u003e\n\u003cli\u003e\u003cbr\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eResearch Data\u003c\/h2\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"10\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStudy\/model\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eReported effect\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHuman observational studies (older adults)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↓ endogenous MOTS-c levels correlate with insulin resistance and aging\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal models (diet-induced obesity)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↓ fat accumulation, ↑ insulin sensitivity, and restored glucose tolerance\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExercise physiology studies\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↑ endurance performance and mitochondrial gene expression in muscle\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCellular stress models\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↑ AMPK activation and mitochondrial ROS reduction under oxidative stress\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh-fat diet mice\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↓ hepatic lipid accumulation and improved metabolic parameters\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIn vitro myocyte cultures\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↑ GLUT4 expression and glucose uptake after peptide exposure\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHuman pilot trial (2022)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eSafe SubQ administration; improved fasting glucose and perceived energy\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLongevity studies (aged mice)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e↑ median lifespan and improved skeletal muscle mitochondrial function\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eStack Suggestions\u003c\/h2\u003e\n\u003cp\u003eIn extended experimental designs, MOTS-c is sometimes paired with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNAD+ (synergistic mitochondrial biogenesis, energy)\u003c\/li\u003e\n\u003cli\u003eSS-31 (mitochondrial antioxidant and protector)\u003c\/li\u003e\n\u003cli\u003eBPC-157 (tissue recovery, cellular stress defense)\u003c\/li\u003e\n\u003cli\u003eEpitalon (anti-aging, telomere function support)\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStacks discussed are for experimental design only, not safety\/efficacy guidance.\u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp\u003eMOTS-c, as a research peptide regulating metabolism, may induce various side effects in experimental models, primarily related to its influence on energy systems. These effects are often dose-dependent and more prominent during initial administration. It’s crucial to monitor subjects closely, as subcutaneous delivery can sometimes cause localized reactions.\u003c\/p\u003e\n\u003cp\u003eInjection Site Reactions: Commonly observed, manifesting as redness or swelling that resolves within hours. Rotating sites minimizes this.\u003cbr\u003eFatigue: A sense of lethargy reported early on, possibly due to metabolic shifts. It often resolves as homeostasis stabilizes.\u003cbr\u003eNausea: Mild gastrointestinal upset, linked to AMPK activation. Typically transient.\u003cbr\u003eHeadache: Occasional, attributed to vascular adjustments.\u003c\/p\u003e\n\u003cp\u003eMost side effects are transient and manageable through dose adjustments in research settings. However, prolonged exposure warrants vigilance for potential hypersensitivity, though rare in controlled protocols.\u003c\/p\u003e\n\u003ch2\u003eScientific References\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12257629\/\"\u003eMitochondria-derived peptide MOTS-c restores mitochondrial …\u003c\/a\u003e  Animal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.innerbody.com\/mots-c-peptide\"\u003eMOTS-c Peptide | Benefits, Safety, \u0026amp; Buying Advice\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eAnimal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.nature.com\/articles\/s12276-025-01521-1\"\u003eMitochondrial-encoded peptide MOTS-c prevents pancreatic islet …\u003c\/a\u003e  Animal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/e-dmj.org\/journal\/view.php?number=2725\"\u003eMitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging …\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eAnimal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.ipharmapharmacy.com\/mots-c-peptide-therapy-2025-blueprint-metabolic-health-longevity-2\/\"\u003eMOTS-c Peptide Therapy: The Definitive 2025+ Blueprint for …\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eReview\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2023.1120533\/full\"\u003eMOTS-c: A promising mitochondrial-derived peptide for therapeutic …\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eAnimal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03885-2\"\u003eMitochondria-derived peptide MOTS-c: effects and mechanisms …\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eAnimal\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/swolverine.com\/blogs\/blog\/mots-c-peptide-benefits-mechanism-and-side-effects-explained?srsltid=AfmBOoojCf9xxOCgMao3nPc_fY9-kTTb-scsTEH5RG_CXIf9ufDTi-Pm\"\u003eMOTS-c Peptide: Benefits, Mechanism, and Side Effects Explained\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eReview\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.hubmeded.com\/blog\/what-is-mots-c\"\u003eWhat Is MOTS-C? Mitochondrial Peptide for Anti-Aging Explained\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eReview\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/polarispeptides.com\/mots-c-peptide-mechanism-benefits-research\/\"\u003eMOTS-c Peptide: Mechanism, Benefits, and Research Applications\u003c\/a\u003e\u003cspan\u003e \u003c\/span\u003eReview\u003c\/li\u003e\n\u003cli\u003e\u003cbr\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eFor educational and scientific context only; not intended to diagnose, treat, cure, or prevent any disease.\u003c\/li\u003e\n\u003cli\u003eIf you are pregnant, nursing, have a medical condition, or use prescription medication, consult a qualified professional.\u003c\/li\u003e\n\u003cli\u003eDiscontinue use if sensitivity occurs.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Peptoora","offers":[{"title":"15 Mg","offer_id":61699416850762,"sku":"PE-MW-PEN-003","price":429.0,"currency_code":"EUR","in_stock":true},{"title":"30 Mg","offer_id":61699416883530,"sku":"PE-MW-PEN-004","price":529.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0887\/1139\/7706\/files\/MOTS-c_10mg.png?v=1775794358","url":"https:\/\/peptoora.com\/it\/products\/mots-c-pen","provider":"Peptoora LTD","version":"1.0","type":"link"}